HMGA2 and cervical carcinoma: Thus, miR-142-3p directly targets HMGA1, HMGA2, HMGB1, and HMGB3, inhibiting them through reduction of cell viability, colony formation, migration, and invasion, as well as induction of apoptosis of tumor cells, particularly cervical cancer cells [209].